Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

A compound of Formula (A)

• or a stereoisomer or tautomeric form thereof, wherein:
• is
• is a 6 membered heteroaryl containing one nitrogen atom;
• X is CR7;
• Y is CR8;
• Ra, Rb, Rc and Rd are independently selected from the group consisting of hydrogen, fluoro, bromo, chloro, —CHF2, —CF2-methyl, —CH2F, —CF3, —OCF3, —CN, C3-C4cycloalkyl and —C1-C4alkyl;
• R4 is hydrogen, —C1-C3alkyl or C3-C4cycloalkyl;
• R5 is hydrogen;
• R6 is selected from the group consisting of C2-C6alkyl, and a 3-7 membered saturated ring optionally containing one or more heteroatoms each independently selected from the group consisting of O, S and N, wherein said 3-7 membered saturated ring and said C2-C6alkyl are optionally substituted with one or more substituents each independently selected from the group consisting of hydrogen, —OH, fluoro, oxo, and C1-C4alkyl wherein said C1-C4alkyl is optionally substituted with one or more substituents selected from the group consisting of fluoro and —OH;
• and
• R7 and R8 are each independently selected from the group consisting of hydrogen, methyl, —CN, fluoro, bromo and chloro;
• or a pharmaceutically acceptable salt or a solvate thereof.